[The future of biomarkers in dementia diagnostics].

about

Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients.

P2860

Q36073017-8ACD9B9E-CCF7-4AEB-A992-AACF178E9FCE

P2860

[The future of biomarkers in dementia diagnostics].

Item

http://www.wikidata.org/entity/Q53322182

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

[The future of biomarkers in dementia diagnostics].

@en

[The future of biomarkers in dementia diagnostics].

@nl

type

Item

label

[The future of biomarkers in dementia diagnostics].

@en

[The future of biomarkers in dementia diagnostics].

@nl

prefLabel

[The future of biomarkers in dementia diagnostics].

@en

[The future of biomarkers in dementia diagnostics].

@nl

P1476

[The future of biomarkers in dementia diagnostics].

@en

P2093

P Lewczuk

http://www.w3.org/2001/XMLSchema#string

R Zimmermann

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid-associated depression: a prodromal depression of Alzheimer disease?

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay.

Multiplexed particle-based flow cytometric assays.

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature.

Molecular biology of Alzheimer's dementia and its clinical relevance to early diagnosis and new therapeutic strategies.

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

P2888

s00115-011-3348-x

P304

1385-6, 1388, 1390, passim

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00115-011-3348-X

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Johannes Kornhuber

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21922304

http://www.w3.org/2001/XMLSchema#string

[The future of biomarkers in dementia diagnostics].

about

P2860

P2860

[The future of biomarkers in dementia diagnostics].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698